Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Brian P Hobbs
Affiliation
Dell Medical School, University of Texas at Austin
ORCID
Career Start Year
2008
Papers
112
H Index
34
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37652304
Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Comprehensive Analysis of Randomized Phase 2B Trial of Proton Beam Therapy Versus Intensity Modulated Radiation Therapy.
Int J Radiat Oncol Biol Phys
2024
34341905
Investigating the natural history and prognostic nature of NTRK gene fusions in solid tumors.
Invest New Drugs
2022
35537102
Basket Trials: Review of Current Practice and Innovations for Future Trials.
J Clin Oncol
2022
35385345
Optimal Sequential Predictive Probability Designs for Early-Phase Oncology Expansion Cohorts.
JCO Precis Oncol
2022
36089921
Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC.
JTO Clin Res Rep
2022
36186544
Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations.
Contemp Clin Trials Commun
2022
35128970
Bayesian basket trial design with false-discovery rate control.
Clin Trials
2022
34888892
Predicting outcomes of phase III oncology trials with Bayesian mediation modeling of tumor response.
Stat Med
2022
35267613
The Impact of Radiation Dose to Heart Substructures on Major Coronary Events and Patient Survival after Chemoradiation Therapy for Esophageal Cancer.
Cancers (Basel)
2022
35229311
A hybrid deep learning model for forecasting lymphocyte depletion during radiation therapy.
Med Phys
2022
34755388
A group-sequential randomized trial design utilizing supplemental trial data.
Stat Med
2022
33096027
Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials.
Lancet Respir Med
2021
34665662
Identifying Individualized Risk Profiles for Radiotherapy-Induced Lymphopenia Among Patients With Esophageal Cancer Using Machine Learning.
JCO Clin Cancer Inform
2021
34534613
Current status and application of proton therapy for esophageal cancer.
Radiother Oncol
2021
34448657
A survival mediation model with Bayesian model averaging.
Stat Methods Med Res
2021
34036293
Increased Incidence of Venous Thromboembolism with Cancer Immunotherapy.
Med
2021
34061563
Moving Beyond 3+3: The Future of Clinical Trial Design.
Am Soc Clin Oncol Educ Book
2021
33436486
Incidence of thromboembolism in patients with melanoma on immune checkpoint inhibitor therapy and its adverse association with survival.
J Immunother Cancer
2021
33393051
Outcomes with Partial Breast Irradiation vs. Whole Breast Irradiation: a Meta-Analysis.
Ann Surg Oncol
2021
33267746
Statistical design considerations for trials that study multiple indications.
Stat Methods Med Res
2021
30672395
A functional model for classifying metastatic lesions integrating scans and biomarkers.
Stat Methods Med Res
2020
32053149
HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer.
JAMA Oncol
2020
31862960
Do persons with chronic myeloid leukaemia have normal or near normal survival?
Leukemia
2020
32712894
The Diminishing Impact of Margin Definitions and Width on Local Recurrence Rates following Breast-Conserving Therapy for Early-Stage Invasive Cancer: A Meta-Analysis.
Ann Surg Oncol
2020
32658656
Randomized Controlled Trials.
Chest
2020
32961553
Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes.
Blood
2020
32821110
Endocrine Therapy Plus Anti-HER2 Therapy as Adjuvant Systemic Therapy for Luminal HER2-Positive Breast Cancer: An Analysis of the National Cancer Database.
Breast Cancer (Auckl)
2020
32698967
Comparing Radiation Modalities with Trimodality Therapy Using Total Toxicity Burden.
Int J Radiat Oncol Biol Phys
2020
32528101
Histology-agnostic drug development - considering issues beyond the tissue.
Nat Rev Clin Oncol
2020
32434711
Elucidating Determinants of Survival Disparities Among a Real-world Cohort of Metastatic Breast Cancer Patients: A National Cancer Database Analysis.
Clin Breast Cancer
2020
32160096
Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer.
J Clin Oncol
2020
31479748
Biologically Effective Dose in Stereotactic Body Radiotherapy and Survival for Patients With Early-Stage NSCLC.
J Thorac Oncol
2020
30359480
Feasibility of fine-needle aspiration for assessing responses to chemotherapy in metastatic nodes marked with clips in breast cancer: A prospective registry study.
Cancer
2019
35100726
Basket Designs: Statistical Considerations for Oncology Trials.
JCO Precis Oncol
2019
31743629
Reprioritizing Risk and Benefit: The Future of Study Design in Early-Phase Cancer Research.
Ethics Hum Res
2019
31792304
Real-world Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National Cancer Database Analysis.
Sci Rep
2019
30037304
Estimating mean local posterior predictive benefit for biomarker-guided treatment strategies.
Stat Methods Med Res
2019
31292802
Phase II study of Dovitinib in recurrent glioblastoma.
J Neurooncol
2019
31427205
Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study.
Lancet Oncol
2019
31097024
A phase II trial of intermittent nivolumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior anti-angiogenic therapy.
J Immunother Cancer
2019
30947241
Correction: Time to initial cancer treatment in the United States and association with survival over time: An observational study.
PLoS One
2019
30822350
Time to initial cancer treatment in the United States and association with survival over time: An observational study.
PLoS One
2019
30962976
The promise and challenges of deep learning models for automated histopathologic classification and mutation prediction in lung cancer.
J Thorac Dis
2019
30786040
Bayesian personalized treatment selection strategies that integrate predictive with prognostic determinants.
Biom J
2019
26763586
Controlled multi-arm platform design using predictive probability.
Stat Methods Med Res
2018
30082477
A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma.
Clin Cancer Res
2018
30079369
Lymphocyte-Sparing Effect of Proton Therapy in Patients with Esophageal Cancer Treated with Definitive Chemoradiation.
Int J Part Ther
2018
29984488
Bayesian basket trial design with exchangeability monitoring.
Stat Med
2018
29949418
Utility of Intermediate-Delay Washout CT Images for Differentiation of Malignant and Benign Adrenal Lesions: A Multivariate Analysis.
AJR Am J Roentgenol
2018
31439980
Spatial Bayesian modeling of GLCM with application to malignant lesion characterization.
J Appl Stat
2018
1 - 50 of 112
Column Actions
Search
Recommended Authors
Fang-I Chu
David Geffen School of Medicine, University of California los angeles
Career Start Year
2018
Number of shared co-authors
1
Xinlei Mi
Feinberg School of Medicine, Northwestern University
Career Start Year
2018
Number of shared co-authors
0
Holly E Hartman
Case Western Reserve University
Career Start Year
2018
Number of shared co-authors
0
Michael A Golafshar
Mayo Clinic
Career Start Year
2018
Number of shared co-authors
0
Xiaoyan Wang
University of California Los Angeles
Career Start Year
2017
Number of shared co-authors
0
Christine B Peterson
University of Texas MD Anderson Cancer Center
Career Start Year
2013
Number of shared co-authors
14
Raquel Perez-Lopez
Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus
Career Start Year
2010
Number of shared co-authors
0
Inna Y Gong
University of Toronto
Career Start Year
2010
Number of shared co-authors
0
Kelley M Kidwell
University of Michigan School of Public Health ann arbor
Career Start Year
2009
Number of shared co-authors
0
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year
2009
Number of shared co-authors
6
Saskia Liti??re
Center for Statistics, Hasselt University
Career Start Year
2007
Number of shared co-authors
0
Eric C Polley
Mayo Clinic
Career Start Year
2007
Number of shared co-authors
0
Sunita Ghosh
Cross Cancer Institute
Career Start Year
2006
Number of shared co-authors
0
Kouros Owzar
Duke University
Career Start Year
2005
Number of shared co-authors
4
Qian Shi
117902Beijing TongRen Hospital, Capital Medical University
Career Start Year
2004
Number of shared co-authors
1
Pavlos Msaouel
The University of Texas MD Anderson Cancer Center
Career Start Year
2004
Number of shared co-authors
4
Chaya S Moskowitz
Memorial Sloan Kettering Cancer Center.
Career Start Year
2002
Number of shared co-authors
0
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year
2001
Number of shared co-authors
2
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year
2001
Number of shared co-authors
1
Pingfu Fu
Case Western Reserve University
Career Start Year
2000
Number of shared co-authors
1
Ronghui Xu
University of California San Diego
Career Start Year
2000
Number of shared co-authors
0
Jeffrey S Morris
Perelman School of Medicine, University of Pennsylvania
Career Start Year
1999
Number of shared co-authors
11
Katherine S Panageas
Memorial Sloan Kettering Cancer Center
Career Start Year
1996
Number of shared co-authors
1
Ming-Hui Chen
Boston Children's Hospital and Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year
1994
Number of shared co-authors
1
Madhu Mazumdar
Icahn School of Medicine at Mount Sinai
Career Start Year
1992
Number of shared co-authors
0
Wei Xu
Princess Margaret Cancer Centre
Career Start Year
1991
Number of shared co-authors
0
Rebecca A Betensky
New York University.
Career Start Year
1987
Number of shared co-authors
2
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year
1986
Number of shared co-authors
11
Dianne M Finkelstein
Harvard Medical School
Career Start Year
1985
Number of shared co-authors
1
Richard Simon
National Cancer Institute
Career Start Year
1975
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Steven H Lin
University of Texas MD Anderson Cancer Center
Co-authored papers
17
Radhe Mohan
The University of Texas MD Anderson Cancer Center
Co-authored papers
6
Dalliah M Black
Co-authored papers
4
Kelly K Hunt
The University of Texas MD Anderson Cancer Center
Co-authored papers
4
Benjamin D Smith
Co-authored papers
3
Peter Balter
University of Texas MD Anderson Cancer Center
Co-authored papers
3
Clifton D Fuller
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Co-authored papers
2
Tinsu Pan
University of Texas MD Anderson Cancer Center
Co-authored papers
2
Eric A Klein
Cleveland Clinic
Co-authored papers
2
Jianhua Hu
Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences
Co-authored papers
2
Laurence E Court
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
David I Rosenthal
MD Anderson Cancer Center
Co-authored papers
2
Wenhua Cao
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Co-authored papers
2
Simona F Shaitelman
University of Texas MD Anderson Cancer Center
Co-authored papers
2
Donald A Berry
MD Anderson Cancer Center
Co-authored papers
1
David M Peereboom
Brain Tumor & Neuro-Oncology Cleveland Clinic Main Campus
Co-authored papers
1
Rahul D Tendulkar
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers
1
Joseph G Ibrahim
University of North Carolina
Co-authored papers
1
Beth M Beadle
Stanford University
Co-authored papers
1
Alda L Tam
MD Anderson Cancer Center
Co-authored papers
1
Rivka R Colen
Co-authored papers
1
Wendy Kimryn Rathmell
Co-authored papers
1
Daniel R Gomez
Memorial Sloan Kettering Cancer Center
Co-authored papers
1
Anirban Maitra
The University of Texas MD Anderson Cancer Center
Co-authored papers
1
Scott Kopetz
University of Texas MD Anderson Cancer Center
Co-authored papers
1
Ashraf Yaseen
School of Public Health, The University of Texas Health Science Center at Houston
Co-authored papers
1
Eric Kodish
Cleveland Clinic and Lerner College of Medicine at Case Western Reserve University
Co-authored papers
1
Goo Jun
University of Texas Health Science Center at Houston
Co-authored papers
1
1 - 30